Czech buyout to make Serum Institute largest polio vaccine
Serum Institute of India, which today acquired a defunct injectable polio vaccine unit in the Czech Republic for 72 million euros, said it expects to shift 15-20 per cent of its production overseas over the next three years with this deal.
Serum Institute of India, which today acquired a defunct injectable polio vaccine unit in the Czech Republic for 72 million euros, said it expects to shift 15-20 per cent of its production overseas over the next three years with this deal.
"Today we make 1.2 billion units/doses of vaccines annually. Only around 2 per cent of this is done overseas now.
With the acquisition of the Florida-based Nanotherapeutics' Czech unit, we hope to take this to around 15-20 per cent over the next three years," Serum Institute chief executive Adar C Poonawalla told
(This article has not been edited by DNA's editorial team and is auto-generated from an agency feed.)